Share purchase by Simon Lee-LXI Investment Advisor
21 June 2023
LXI REIT PLC
("LXI REIT" or the "Company")
SHARE PURCHASE BY SIMON LEE, FUND MANAGER OF THE COMPANY'S INVESTMENT ADVISOR
The Board of LXI REIT (ticker: LXI), the specialist inflation-protected very long income REIT, announces that Simon Lee, Fund Manager of the Company's Investment Advisor, LXI REIT Advisors Limited, acquired 107,621 ordinary shares in the capital of the Company at 93.0 pence per share for a total cost of £99,839 on 20 June 2023.
FOR FURTHER INFORMATION, PLEASE CONTACT:
|
LXI REIT Advisors Limited Simon Lee (Partner, Fund Manager) John White (Partner, Fund Manager) Freddie Brooks (CFO) |
Via H/Advisors Maitland |
|
|
|
|
|
|
|
Barclays Bronson Albery / Tom Macdonald / Dion Miceli |
020 7623 2323 |
|
|
|
|
|
|
|
Jefferies International Tom Yeadon / Ed Matthews / Rishi Bhuchar |
020 7029 8000 |
|
|
|
|
H/Advisors Maitland (Communications Advisor) James Benjamin / Rachel Cohen |
07747 113 930 / 020 7379 5151 lxireit-maitland@h-advisors.global |
The Company's LEI is: 2138008YZGXOKAXQVI45
NOTES
LXI REIT plc invests in commercial property assets predominantly in the UK, let, or pre-let, on long (typically 20 to 30 years to expiry or first break), inflation-linked leases to a wide range of strong tenant covenants across a diverse range of robust property sectors.
The Company may invest in fixed-price forward funded developments, provided they are pre-let to an acceptable tenant and full planning permission is in place. The Company will not undertake any direct development activity nor assume direct development risk.
The Company is targeting a dividend of 6.6 pence per ordinary share for the year which commenced on 1 April 2023*.
The Company, a real estate investment trust ("REIT") incorporated in England and Wales, is listed on the premium listing segment of the Official List of the UK Financial Conduct Authority and was admitted to trading on the main market for listed securities of the London Stock Exchange in February 2017.
The Company is a constituent of the FTSE 250, EPRA/NAREIT, MSCI and STOXX Europe 600 indices.
Further information on the Company is available at www.lxireit.com
* This is a target and not profit forecast.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 1 hour ago Cambridge Cognition Holdings
- 1 hour ago Shell
- 1 hour ago Centrica
- 2 hours ago Optima Health
- 3 hours ago Centrica